
### [NCIT:C3771](http://purl.obolibrary.org/obo/NCIT_C3771)
**Label:** Lobular Breast Carcinoma

**Subclasses:** [NCIT:C4018](http://purl.obolibrary.org/obo/NCIT_C4018) (Lobular Breast Carcinoma In Situ), [NCIT:C97049](http://purl.obolibrary.org/obo/NCIT_C97049) (Invasive Lobular Breast Carcinoma, Alveolar Variant), [NCIT:C54691](http://purl.obolibrary.org/obo/NCIT_C54691) (Invasive Lobular Breast Carcinoma, Signet Ring Variant), [NCIT:C76328](http://purl.obolibrary.org/obo/NCIT_C76328) (Metastatic Lobular Breast Carcinoma), [NCIT:C7950](http://purl.obolibrary.org/obo/NCIT_C7950) (Invasive Lobular Breast Carcinoma), [NCIT:C97051](http://purl.obolibrary.org/obo/NCIT_C97051) (Invasive Lobular Breast Carcinoma, Pleomorphic Variant), [NCIT:C137839](http://purl.obolibrary.org/obo/NCIT_C137839) (Pleomorphic Lobular Breast Carcinoma In Situ), [NCIT:C97052](http://purl.obolibrary.org/obo/NCIT_C97052) (Invasive Lobular Breast Carcinoma, Solid Variant), [NCIT:C97053](http://purl.obolibrary.org/obo/NCIT_C97053) (Invasive Lobular Breast Carcinoma, Tubulolobular Variant), 

**Class expressions from DL-Learner:**

- Thing 54.00%
- [NCIT:C36879](http://purl.obolibrary.org/obo/NCIT_C36879) (Lobular Carcinoma Cell) 52.00%
- [NCIT:C36878](http://purl.obolibrary.org/obo/NCIT_C36878) (Neoplastic Lobular Epithelial Cell) 52.00%
- [NCIT:C36877](http://purl.obolibrary.org/obo/NCIT_C36877) (Neoplastic Ductal Epithelial Cell) 52.00%
- [NCIT:C36858](http://purl.obolibrary.org/obo/NCIT_C36858) (Ductal Carcinoma Cell) 52.00%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 37.36%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39124](http://purl.obolibrary.org/obo/NCIT_C39124) (IL3 Signaling Pathway))) 37.36%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39123](http://purl.obolibrary.org/obo/NCIT_C39123) (IL2RB Pathway))) 37.36%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39121](http://purl.obolibrary.org/obo/NCIT_C39121) (IL22 Signaling Pathway))) 37.36%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39117](http://purl.obolibrary.org/obo/NCIT_C39117) (IL12 Signaling Pathway))) 37.36%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39114](http://purl.obolibrary.org/obo/NCIT_C39114) (IGF-1 Signaling Pathway))) 37.36%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39112](http://purl.obolibrary.org/obo/NCIT_C39112) (IFN Gamma Signaling Pathway))) 37.36%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39103](http://purl.obolibrary.org/obo/NCIT_C39103) (ERBB2 Signaling Pathway))) 37.36%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39102](http://purl.obolibrary.org/obo/NCIT_C39102) (Skeletal Myogenesis Pathway))) 37.36%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39101](http://purl.obolibrary.org/obo/NCIT_C39101) (Human Cytomegalovirus Infection Pathway))) 37.36%


